| Ms Nannette A Nero, MS, CAGS, LMFT | |
|
62 Portland Rd, Suite 6, Kennebunk, ME 04043-6650 | |
| (207) 985-5580 | |
| (207) 985-5580 |
| Full Name | Ms Nannette A Nero |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 62 Portland Rd, Kennebunk, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205957719 | NPI | - | NPPES |
| 431596000 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MF1940 (Maine) | Primary |
| Entity Name | Nannette Nero Zuke Lmft Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700286721 PECOS PAC ID: 5799138509 Enrollment ID: O20240129002056 |
News Archive
Researchers from the Institute of Psychiatry at King's College London have identified a molecule that could be targeted to treat the cognitive impairment in people with Down syndrome.
Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training.
Gene sequencing company Illumina recently made big waves by announcing a new spinoff, Grail, dedicated to building a test for cancer by sequencing tumor DNA fragments found in blood. The company also reported plans for a separate project to identify single cells and tag them for later analysis.
Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nannette A Nero, MS, CAGS, LMFT Po Box 48, Biddeford, ME 04005-0048 Ph: (207) 985-5580 | Ms Nannette A Nero, MS, CAGS, LMFT 62 Portland Rd, Suite 6, Kennebunk, ME 04043-6650 Ph: (207) 985-5580 |
News Archive
Researchers from the Institute of Psychiatry at King's College London have identified a molecule that could be targeted to treat the cognitive impairment in people with Down syndrome.
Using readily available computer programs, researchers have developed a system to identify genes that will be useful in the classification of breast cancer. The algorithm, described in BioMed Central's open access Journal of Experimental & Clinical Cancer Research will enable researchers to quickly generate valuable gene signatures without specialized software or extensive bioinformatics training.
Gene sequencing company Illumina recently made big waves by announcing a new spinoff, Grail, dedicated to building a test for cancer by sequencing tumor DNA fragments found in blood. The company also reported plans for a separate project to identify single cells and tag them for later analysis.
Characteristics like seizures, location of the tumour, and pressure in the brain, give insight into length of survival and treatment options for brain tumour patients over the age of 70, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.
› Verified 9 days ago
Ms. Anne Lindquist, M.A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 2 Storer St Ste 403b, Kennebunk, ME 04043 Phone: 801-513-8354 |